Acquisition

Genova Diagnostics appoints Keith Meadors as CCO, signaling an aggressive commercial strategy following its recent acquisition of Cell Science Systems.

Howard Hughes Holdings adds former Arch Capital CEO Marc Grandisson to its board, a move backed by a $10M investment, signaling a major push into insurance.

New research confirms 40% of mobile user issues are invisible to carriers. A tiny chip in your phone is about to change everything, promising fewer dropped calls.

Andersen appoints Shawn Brown to lead Bright Wood, implementing a unique 'hands-off' strategy to preserve the supplier's independence and market neutrality.

With new leadership and a focus on acquisitions, Bookkeeper360 aims to modernize the accounting industry using its proprietary AI platform and tech.

With multiple top honors at the 2026 EdTech Digest Awards, Cambium Learning Group cements its role as a leader in literacy and teacher development.

A major shareholder has increased its stake to 10% and declared war on GFL's acquisition of SECURE Waste, arguing the deal undervalues the company.

Everon wins a top industry award for its high-tech security at a Robbins Brothers jeweler, showcasing major growth since its private equity-backed relaunch.

A massive new investment in SubCom, the USA's only end-to-end subsea cable maker, highlights the critical, high-stakes race to control global data.

Ribbon mic leader Royer Labs has acquired boutique gear maker Undertone Audio, a major consolidation backed by new holding company Sounds Great Holdings.

Former Naval Aviator Tricia Shaw brings a 'mission-first' mindset from Morgan Stanley to AXOM Partners, fueling the boutique firm's rapid rise in AI M&A.

The fast-growing sandwich giant has confidentially filed for a major IPO. Here's what the move means for its growth, its rivals, and the restaurant industry.

As AI projects falter on bad data, companies learn that automation without human oversight is a risky bet, especially in regulated industries.

A $300M deal for mobile natural gas highlights a new strategy to power the AI boom as data centers face decade-long waits for grid connections.

With Cigna's backing, Accord's IMULDOSA is set to challenge a blockbuster drug, promising significant savings for patients and the healthcare system.

NAMSA appoints commercial leader Scott Day as VP, signaling a strategic push to expand its end-to-end clinical and consulting services amid industry growth.

Ionic Digital's Bitcoin output fell in March, but a debt-free strategy and a major AI deal suggest a calculated shift toward long-term stability.

Biogen consolidates worldwide rights for its promising immunology drug felzartamab, acquiring China rights from TJ Biopharma in a strategic $850M deal.

Chinese tech giant Tencent invests in Kaspi.kz, a major endorsement of the Kazakh fintech's Super App model as it accelerates its expansion into Türkiye.

A Shanghai-based firm's new approach could create cancer-fighting cells inside the body, slashing costs and wait times for CAR-T therapy.